Therapeutic Areas

Oncology Clinical Development Expertise

Cancer Clinical Development is Complex, Our Experts Can Help

Veristat has extensive experience supporting 700 oncology projects and marketing applications in the United States, Europe, and Japan. We help oncology developers navigate the complexities of designing and executing their cancer trials in the most highly competitive and complicated market. Our extensive expertise includes traditional cancer treatments, devices/diagnostics as well as specialized therapies including vaccines, gene therapies, cell therapies, and immunotherapies.

Oncology Experience

With cancer being the second* leading cause of death today, it’s no wonder that Veristat’s clients are prioritizing their pipelines to develop life-extending cancer therapies.

Veristat's teams work on a spectrum of amazing cancer treatments including drugs, vaccines, and diagnostics.

Cancer clinical development comprises >35% of the work we do
Cancer treatments account for 50% of the marketing applications that our teams have prepared,
In the past 5 years, 10 oncology products were approved for NDAs and jNDAs that we prepared

*Source: http://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm

Hematologic Malignancies/Blood Cancers
Acute Myeloid Leukemia (AML)	Metastatic Non-Hematologic Malignancies
B-Cell Lymphoma	Multiple Myeloma (MM)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)	Myelodysplastic Syndromes (MDS)
Chronic Lymphocytic Leukemia (CLL)	Myeloid Leukemia
Cutaneous T-Cell Lymphoma (CTCL)	Myeloproliferative Neoplasm
Diffuse Large B-Cell Lymphoma (DLBCL)	Non-Hodgkin's Lymphoma (NHL)
Essential Thrombocythemia	Peripheral T-cell Lymphoma (PTCL)
Follicular Lymphoma	Richter's Transformation (RT)
Hodgkin’s Lymphoma	Systemic Mastocytosis (SM)
Mantle Cell Lymphoma	T Cell Lymphoma
Mantle Cell NHL	Waldenstrom's Macroglobulinemia

Solid Tumor Indications
Advanced/Metastatic Solid Tumors	Melanoma
Biliary Cancer	Non-Small Cell Lung Cancer (NSCLC)
Bladder Cancer	Ovarian Cancer
Brain Cancer	Pancreatic Cancer
Breast Cancer	Prostate Cancer
Cervical Cancer / Dysplasia	Rectal Cancer
Cholangiocarcinoma/Bile Duct	Renal Cell Carcinoma (RCC)
Colorectal Cancer	Small Cell Lung Cancer (SCLC)
Gastric Cancer	Synovial Tumors
Head & Neck Tumors	Thyroid Cancer
Hepatocellular Carcinoma (HCC)	Urothelial Carcinoma
Human Papilloma Virus (HPV) Cancers	Vulva Cancer

Cancer Diagnostic Imaging
Lymph Node Imaging - MRI Contract Agent	Mammography for Breast Cancer Diagnosis
Lymph Node Imaging for Prostate Cancer

Chemotherapy Side Effects
Chemotherapy-induced Alopecia	Chemotherapy Induced Pain Management
Chemotherapy-induced nausea and vomiting (CINV)	Chemotherapy Induced Peripheral Neuropathy

Solutions Span Early to Late Phase

Our solutions span the entire clinical development life-cycle - and are offered as a comprehensive, all-inclusive solution or as functional support. We offer strategic guidance for informed decision-making, operational support to mitigate trial risks, the statistical knowledge to prove safety and efficacy, the medical oversight to ensure patient safety, and the regulatory expertise to achieve approval success.

early_to_late_phase_experience